Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 01GQ1420B)
Received: 1 October 2018
Accepted: 20 March 2019
First Online: 1 May 2019
Ethics approval and consent to participate
: The study protocol, participant information sheet, and participant informed consent were submitted for ethical review and have received approval from the Ethics Committee of the Charité – Universitätsmedizin, Berlin, Germany (EA1/ 250 /16, date of first approval: 13.10.2016). The FBB PET measurements were approved by the Federal Radiation Protection Authority (Bundesamt für Strahlenschutz (BfS)) Salzgitter Germany (Z5 – 22461/2 – 2016-010, date of approval: 17.07.2017). All procedures conducted during the SmartAge trial will be carried out in compliance with the Declaration of Helsinki.
: Not applicable
: Slaven Stekovic, Stephan J. Sigrist, and Frank Madeo have a financial interest in TLL. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.